Taurus Asset Management’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Taurus Asset Management’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-30,000	Closed	-$723K	–	103
2014 Q2	$723K	Hold	30,000	–	–	0.14%	76
2014 Q1	$181K	Hold	30,000	–	–	0.04%	102
2013 Q4	$179K	Hold	30,000	–	–	0.04%	104
2013 Q3	$156K	Hold	30,000	–	–	0.04%	100
2013 Q2	$108K	Buy	+30,000	New	+$123K	0.03%	99

Taurus Asset Management's IDIX Position: Q3 2014 in Review

Taurus Asset Management sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 30,000 shares — an estimated $723K sold.

Taurus Asset Management first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $723K in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

Taurus Asset Management reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
Taurus Asset Management sold 30,000 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $723K.
Taurus Asset Management first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
Taurus Asset Management's IDENIX PHARMACEUTICALS INC position peaked at $723K in Q2 2014.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Taurus Asset Management's 13F filing for Q3 2014, filed 14 Nov 2014.